Tadashi Kamei

1.4k total citations
41 papers, 870 citations indexed

About

Tadashi Kamei is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Surgery. According to data from OpenAlex, Tadashi Kamei has authored 41 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 11 papers in Physiology and 7 papers in Surgery. Recurrent topics in Tadashi Kamei's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Asthma and respiratory diseases (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Tadashi Kamei is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), Asthma and respiratory diseases (9 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (6 papers). Tadashi Kamei collaborates with scholars based in Japan, United States and Sweden. Tadashi Kamei's co-authors include Jiro Fujita, Takeo Yoshinouchi, J Takahara, Y Ohtsuki, Junko Ishizeki, Haruka Yamaguchi, Yuichi NAKAZATO, Kei Takahashi, Taketoshi Mori and Ichiro Yamadori and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, European Respiratory Journal and Thorax.

In The Last Decade

Tadashi Kamei

41 papers receiving 842 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tadashi Kamei Japan 19 512 213 161 140 136 41 870
Tomoko Haba Japan 13 150 0.3× 145 0.7× 146 0.9× 253 1.8× 169 1.2× 30 928
Elisa Lappi‐Blanco Finland 19 546 1.1× 121 0.6× 128 0.8× 116 0.8× 103 0.8× 41 809
Satoshi Shiraishi Japan 15 160 0.3× 189 0.9× 203 1.3× 106 0.8× 78 0.6× 52 783
C. Cullinane United Kingdom 19 378 0.7× 54 0.3× 428 2.7× 176 1.3× 175 1.3× 33 1.0k
Robert A. Mickel United States 16 219 0.4× 187 0.9× 80 0.5× 242 1.7× 234 1.7× 32 797
Keizo Kageyama Japan 15 398 0.8× 62 0.3× 108 0.7× 91 0.7× 162 1.2× 47 718
Dennis M. Frisman United States 15 252 0.5× 238 1.1× 127 0.8× 176 1.3× 344 2.5× 23 956
Keisuke Nishimura Japan 15 249 0.5× 102 0.5× 111 0.7× 61 0.4× 103 0.8× 74 682
H. Moses United States 6 138 0.3× 169 0.8× 362 2.2× 104 0.7× 207 1.5× 8 692
Elisabeth Peen Norway 15 150 0.3× 311 1.5× 82 0.5× 139 1.0× 35 0.3× 26 823

Countries citing papers authored by Tadashi Kamei

Since Specialization
Citations

This map shows the geographic impact of Tadashi Kamei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Kamei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Kamei more than expected).

Fields of papers citing papers by Tadashi Kamei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Kamei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Kamei. The network helps show where Tadashi Kamei may publish in the future.

Co-authorship network of co-authors of Tadashi Kamei

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Kamei. A scholar is included among the top collaborators of Tadashi Kamei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Kamei. Tadashi Kamei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niimi, Akio, Junpei Saito, Tadashi Kamei, et al.. (2021). Randomised trial of the P2X3receptor antagonist sivopixant for refractory chronic cough. European Respiratory Journal. 59(6). 2100725–2100725. 39 indexed citations
2.
Máspero, Jorge, Ioana Agache, Tadashi Kamei, et al.. (2021). Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial. Respiratory Research. 22(1). 311–311. 4 indexed citations
3.
4.
FitzGerald, J Mark, Ken Ohta, Mitsuru Adachi, et al.. (2017). Benralizumab Reduces Exacerbations in Japanese Patients with Severe, Uncontrolled Asthma: Subgroup Analysis of the Calima Trial. Journal of Allergy and Clinical Immunology. 139(2). AB10–AB10. 1 indexed citations
5.
Ohta, Ken, Mitsuru Adachi, Yuji Tohda, et al.. (2017). Efficacy and safety of benralizumab in Japanese patients with severe, uncontrolled eosinophilic asthma. Allergology International. 67(2). 266–272. 21 indexed citations
6.
Shimizu, Keiko, Yasuhiro Yamasaki, Hiroki Okada, et al.. (2007). Effect of Low-Dose Theophylline on Airway Resistance, Respiratory Muscle Strength, and High-Sensitivity C-reactive Protein in Patients with Chronic Obstructive Pulmonary Disease. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 33(2). 141–144. 2 indexed citations
7.
Yamazaki, Yasuhiro, et al.. (2003). [Low-dose multi-slice CT (LMCT) assessment of pulmonary emphysema in public-school teachers].. PubMed. 41(11). 771–6. 1 indexed citations
8.
Matsuhashi, Yoshiko, et al.. (2001). Successful Therapy of Pure Red Cell Aplasia Secondary to Plasma Cell Dyscrasia with Bolus Methylprednisolone.. Internal Medicine. 40(8). 802–804. 2 indexed citations
9.
Hirasaki, Shoji, Tadashi Kamei, Yoko Iwasaki, et al.. (2000). Churg-Strauss Syndrome with Pleural Involvement.. Internal Medicine. 39(11). 976–978. 9 indexed citations
10.
11.
Fujita, Jiro, Yuji Ohtsuki, Ichiro Yamadori, et al.. (2000). Circulating Cytokeratin 8:Anti-Cytokeratin 8 Antibody Immune Complexes in Sera of Patients with Pulmonary Fibrosis. Respiration. 67(4). 397–401. 22 indexed citations
12.
Obayashi, Yuka, Jiro Fujita, Ichizo Suemitsu, et al.. (1999). Successive follow-up of chest computed tomography in patients with Mycobacterium avium-intracellulare complex. Respiratory Medicine. 93(1). 11–15. 40 indexed citations
13.
14.
Yamanouchi, Hideo, Jiro Fujita, Takeo Yoshinouchi, et al.. (1998). Measurement of hepatocyte growth factor in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. Respiratory Medicine. 92(2). 273–278. 36 indexed citations
15.
Yamanouchi, Hideo, Jiro Fujita, Satoko Hojo, et al.. (1998). Neutrophil elastase: alpha-1-proteinase inhibitor complex in serum and bronchoalveolar lavage fluid in patients with pulmonary fibrosis. European Respiratory Journal. 11(1). 120–125. 36 indexed citations
16.
Hojo, Satoko, Jiro Fujita, Ichiro Yamadori, et al.. (1998). Overexpression of p53 protein in interstitial lung diseases. Respiratory Medicine. 92(2). 184–190. 8 indexed citations
17.
Hojo, Satoko, Jiro Fujita, Takeo Yoshinouchi, et al.. (1997). Hepatocyte growth factor and neutrophil elastase in idiopathic pulmonary fibrosis. Respiratory Medicine. 91(9). 511–516. 14 indexed citations
18.
Takada, Minoru, Shunichi Negoro, Kiyoyuki Furuse, et al.. (1997). Activity of gemcitabine in non-small-cell lung cancer: results of the Japan gemcitabine group (A) phase II study. Cancer Chemotherapy and Pharmacology. 41(3). 217–222. 19 indexed citations
19.
Kamei, Tadashi, et al.. (1994). Pulmonary Inflammatory Pseudotumor Complicated with Left Total Lung Atelectasis due to Intrabronchial Growth. 16(4). 357–362. 1 indexed citations
20.
Kamei, Tadashi, et al.. (1993). Two cases of nasopharyngeal branchial cyst. The Journal of Laryngology & Otology. 107(5). 453–455. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomoko Haba Breakdown of academic impact, for papers by Elisa Lappi‐Blanco Breakdown of academic impact, for papers by Satoshi Shiraishi Breakdown of academic impact, for papers by C. Cullinane Breakdown of academic impact, for papers by Robert A. Mickel Breakdown of academic impact, for papers by Keizo Kageyama Breakdown of academic impact, for papers by Dennis M. Frisman Breakdown of academic impact, for papers by Keisuke Nishimura Breakdown of academic impact, for papers by H. Moses Breakdown of academic impact, for papers by Elisabeth Peen
Rankless by CCL
2026